Skip to main content
Top
Published in: Clinical Reviews in Allergy & Immunology 3/2018

01-06-2018

Role of Mast Cells in Regulation of T Cell Responses in Experimental and Clinical Settings

Authors: Daniel Elieh Ali Komi, Korneel Grauwet

Published in: Clinical Reviews in Allergy & Immunology | Issue 3/2018

Login to get access

Abstract

Mast cells secrete a wide spectrum of stored or newly synthesized pro-inflammatory, anti-inflammatory, and/or immunosuppressive mediators and express several costimulatory and inhibitory surface molecules. Mast cells finely tune activities of T cells, B cells, and regulatory cells and effectively contribute to the development of different T cell-associated responses by influencing their recruitment, activation, proliferation, and differentiation. The interaction between mast cells and T cells, with regard to cellular functionality and immune responses, can be assessed in both activating and inhibitory regulations. While Th2 cytokines, including IL-5 and IL-9, stimulate stem cell factor (SCF)-dependent proliferation of mast cells, Th1 cytokine IFN-γ suppresses SCF-mediated differentiation of mast cell progenitors. Mast cell mediators such as CCL5 have a role in the recruitment of CD8+ T cells to viral infection sites where their ability in clearance of viral reservoirs is needed. The capacity of mast cells in presenting antigens by classes I and II MHC molecules to CD4+ and CD8+ T cells respectively is considered one of the main antigen-dependent interactions of mast cells with T cells. Interestingly, Tregs recruit mast cells to different sites through secretion of IL-9, while the OX40L (expressed on mast cell)-OX40(expressed on T cell) interaction inhibits the extent of the mast cell degranulation. Recently, the capability of exosomes to carry regulatory receptors of the mast cell surface and their role in T cell activation has been investigated. Functional interplay between mast cells and T cell subsets has been suggested primarily by investigating their co-localization in inflamed tissues and involvement of mast cells in autoimmune diseases. In this review, the interactions of mast cells with T cells are reviewed in cell-to-cell, cytokine, and exosome categories.
Literature
15.
go back to reference Malaviya R, Twesten NJ, Ross EA, Abraham SN, Pfeifer JD (1996) Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J Immunol (Baltimore, Md : 1950) 156(4):1490–1496 Malaviya R, Twesten NJ, Ross EA, Abraham SN, Pfeifer JD (1996) Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J Immunol (Baltimore, Md : 1950) 156(4):1490–1496
22.
go back to reference Yeatman CF 2nd, Jacobs-Helber SM, Mirmonsef P, Gillespie SR, Bouton LA, Collins HA, Sawyer ST, Shelburne CP, Ryan JJ (2000) Combined stimulation with the T helper cell type 2 cytokines interleukin (IL)-4 and IL-10 induces mouse mast cell apoptosis. J Exp Med 192(8):1093–1103CrossRefPubMedPubMedCentral Yeatman CF 2nd, Jacobs-Helber SM, Mirmonsef P, Gillespie SR, Bouton LA, Collins HA, Sawyer ST, Shelburne CP, Ryan JJ (2000) Combined stimulation with the T helper cell type 2 cytokines interleukin (IL)-4 and IL-10 induces mouse mast cell apoptosis. J Exp Med 192(8):1093–1103CrossRefPubMedPubMedCentral
32.
go back to reference Suurmond J, Habets KL (2016) Expansion of Th17 cells by human mast cells is driven by inflammasome-independent IL-1beta. J Immunol 197(11):4473–4481CrossRefPubMed Suurmond J, Habets KL (2016) Expansion of Th17 cells by human mast cells is driven by inflammasome-independent IL-1beta. J Immunol 197(11):4473–4481CrossRefPubMed
38.
go back to reference Shelburne CP, Ryan JJ (2001) The role of Th2 cytokines in mast cell homeostasis. Immunol Rev 179:82–93CrossRefPubMed Shelburne CP, Ryan JJ (2001) The role of Th2 cytokines in mast cell homeostasis. Immunol Rev 179:82–93CrossRefPubMed
39.
go back to reference Bailey DP, Kashyap M, Mirmonsef P, Bouton LA, Domen J, Zhu J, Dessypris EN, Ryan JJ (2004) Interleukin-4 elicits apoptosis of developing mast cells via a Stat6-dependent mitochondrial pathway. Exp Hematol 32(1):52–59CrossRefPubMed Bailey DP, Kashyap M, Mirmonsef P, Bouton LA, Domen J, Zhu J, Dessypris EN, Ryan JJ (2004) Interleukin-4 elicits apoptosis of developing mast cells via a Stat6-dependent mitochondrial pathway. Exp Hematol 32(1):52–59CrossRefPubMed
40.
go back to reference Yanagida M, Fukamachi H, Ohgami K, Kuwaki T, Ishii H, Uzumaki H, Amano K, Tokiwa T, Mitsui H, Saito H, Iikura Y, Ishizaka T, Nakahata T (1995) Effects of T-helper 2-type cytokines, interleukin-3 (IL-3), IL-4, IL-5, and IL-6 on the survival of cultured human mast cells. Blood 86(10):3705–3714PubMed Yanagida M, Fukamachi H, Ohgami K, Kuwaki T, Ishii H, Uzumaki H, Amano K, Tokiwa T, Mitsui H, Saito H, Iikura Y, Ishizaka T, Nakahata T (1995) Effects of T-helper 2-type cytokines, interleukin-3 (IL-3), IL-4, IL-5, and IL-6 on the survival of cultured human mast cells. Blood 86(10):3705–3714PubMed
44.
go back to reference Nakae S, Suto H, Iikura M, Kakurai M, Sedgwick JD, Tsai M, Galli SJ (2006) Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J Immunol(Baltimore, Md : 1950) 176(4):2238–2248 Nakae S, Suto H, Iikura M, Kakurai M, Sedgwick JD, Tsai M, Galli SJ (2006) Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J Immunol(Baltimore, Md : 1950) 176(4):2238–2248
54.
go back to reference Groot Kormelink T, Abudukelimu A, Redegeld FA (2009) Mast cells as target in cancer therapy. Curr Pharm Des 15(16):1868–1878CrossRefPubMed Groot Kormelink T, Abudukelimu A, Redegeld FA (2009) Mast cells as target in cancer therapy. Curr Pharm Des 15(16):1868–1878CrossRefPubMed
55.
go back to reference Christy AL, Brown MA (2007) The multitasking mast cell: positive and negative roles in the progression of autoimmunity. J Immunol (Baltimore, Md : 1950) 179(5):2673–2679CrossRef Christy AL, Brown MA (2007) The multitasking mast cell: positive and negative roles in the progression of autoimmunity. J Immunol (Baltimore, Md : 1950) 179(5):2673–2679CrossRef
68.
go back to reference Schuerwegh AJ, Dombrecht EJ, Stevens WJ, Van Offel JF, Bridts CH, De Clerck LS (2003) Influence of pro-inflammatory (IL-1 alpha, IL-6, TNF-alpha, IFN-gamma) and anti-inflammatory (IL-4) cytokines on chondrocyte function. Osteoarthr Cartil 11(9):681–687CrossRefPubMed Schuerwegh AJ, Dombrecht EJ, Stevens WJ, Van Offel JF, Bridts CH, De Clerck LS (2003) Influence of pro-inflammatory (IL-1 alpha, IL-6, TNF-alpha, IFN-gamma) and anti-inflammatory (IL-4) cytokines on chondrocyte function. Osteoarthr Cartil 11(9):681–687CrossRefPubMed
85.
go back to reference Betto E, Usuelli V, Mandelli A, Badami E, Sorini C, Capolla S, Danelli L, Frossi B, Guarnotta C, Ingrao S, Tripodo C, Pucillo C, Gri G, Falcone M (2017) Mast cells contribute to autoimmune diabetes by releasing interleukin-6 and failing to acquire a tolerogenic IL-10+ phenotype. Clin Immunol (Orlando, Fla) 178:29–38. https://doi.org/10.1016/j.clim.2015.12.013 CrossRef Betto E, Usuelli V, Mandelli A, Badami E, Sorini C, Capolla S, Danelli L, Frossi B, Guarnotta C, Ingrao S, Tripodo C, Pucillo C, Gri G, Falcone M (2017) Mast cells contribute to autoimmune diabetes by releasing interleukin-6 and failing to acquire a tolerogenic IL-10+ phenotype. Clin Immunol (Orlando, Fla) 178:29–38. https://​doi.​org/​10.​1016/​j.​clim.​2015.​12.​013 CrossRef
Metadata
Title
Role of Mast Cells in Regulation of T Cell Responses in Experimental and Clinical Settings
Authors
Daniel Elieh Ali Komi
Korneel Grauwet
Publication date
01-06-2018
Publisher
Springer US
Published in
Clinical Reviews in Allergy & Immunology / Issue 3/2018
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-017-8646-z

Other articles of this Issue 3/2018

Clinical Reviews in Allergy & Immunology 3/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.